Onset of stroke was assessed by the appearance of neurological symptoms (hyperkinetic/hypokinetic behaviors [flitting/immobile], hyper/hyposensitivity [jumping up/no reaction by touch], or proleg lift, piloerection) and physiological changes (decrease in body weight or food intake or increase in drinking water intake) as described previously. 1, 2 Rats were checked for these symptoms by two investigators at 10:00 am every day.
Plasma Chemistry
Plasma IL-1β, IL-6, and TNF-α levels were determined with Quantikine rat IL-1β, IL-6, or TNF-α Immunoassay Kits, respectively (R&D Systems, Inc., Minneapolis, MN). Plasma MCP-1 level was determined with the Endogen Rat MCP-1 ELISA Kit (Pierce Biotechnology, Inc., Rockford, IL). Plasma urea level was measured by a chemiluminescent method using the QuantiChrom Urea Assay Kit (DIUR-500) (BioAssay Systems, Hayward, CA). Plasma was obtained at 10:00 am after overnight fasting.
Cerebrovascular Endothelial Cells
Cerebrovascular endothelial cells (CVECs) were harvested in the manner of previous reports with some modifications [3] [4] [5] . SHRSP with 2 weeks of dietary manipulation were killed and brains were removed. The whole brain of each rat (about 2 grams) was homogenized with a Teflon-pestle homogenizer in 10 ml of 0.32M sucrose buffer (0.32M sucrose, 3 mM HEPES, 10 µM CaCl 2 , pH 7.4). Homogenate was centrifuged (1,000 x g, 10 minutes), and the pellets were re-suspended with 10 ml of 0.32M sucrose buffer. The suspension was centrifuged (100 x g, 15 seconds), and the pellets were re-suspended with 0.4 ml of 0.32M sucrose buffer. This suspension was centrifuged (100 x g, 15 seconds), and the collected supernatant was re-centrifuged (200 x g, 1 minute). The pellet (microvascular-rich fraction) was incubated with DMEM containing dispase (1000 protease units/ml) for 30 minutes. After incubation, cells were centrifuged (1,000 x g, 10 minutes), and the pellet was re-suspended in 1 ml of 0.32M sucrose buffer. CVECs were isolated with Ficoll gradient (7.5, 12, 18, and 32%) ultracentrifugation (53,000 x g, 30 minutes) and collected as cells between 18% and 32% Ficoll. CVECs were washed with PBS and total RNA was extracted using TRIzol Reagent (Invitrogen Co., Carlsbad, CA).
Quantitative RT-PCR
Total RNA was reverse transcribed with the Omniscript RT Kit (QIAGEN, GmbH, Germany) and oligo (dT) primers. Reactions were performed with SYBR Green PCR Master Mix and a 7500 Real-Time PCR System (Applied Biosystems, Foster City, CA). The results are expressed as the copy number ratio of the target mRNA to GAPDH mRNA. The rat-specific primer pairs used are listed as follows: MCP-1 forward 5'-TGCTGTCTCAGCCAGATGCAGTTA-3'; reverse 5'-TACAGCTTCTTTGGGACACCTGCT-3'; ICAM-1 forward 5'-TGCAGGTGAACTGCTCTTCCTCTT-3'; reverse 5'-AGCTTCCAGTTGTGTCCACTCGAT-3'; VCAM-1 forward 5'-TTCCGTTGTTCTGACATGTGCTGC-3'; reverse 5'-ACAGTGCACAGGTAAGAGTGCTCA-3'; GAPDH forward 5'-TGATGCTGGTGCTGAGTATGTCGT-3'; reverse 5'-TCTCGTGGTTCACACCCATCACAA-3';
Statistics
Data are presented as the mean ± SEM. Statistical analysis was conducted using one-way ANOVA with Bonferroni post hoc testing for parametric data (Statview 5.0, Abacus Concepts, Piscataway, NJ). Data from two groups were compared by Student's t test or paired t test. For the onset of stroke and survival curves, a Kaplan-Meier curve was obtained, and the comparison of groups was performed using the Log-Rank test. P<0.05 was considered statistically significant. 
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